HIV study named 2011 breakthrough of the year by Science

NIH-funded treatment-as-prevention study heralded as a major advance

2011-12-23

(Press-News.org) The journal Science has chosen the HPTN 052 clinical trial (http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HPTN052.aspx), an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as the 2011 Breakthrough of the Year. The study found that if HIV-infected heterosexual individuals begin taking antiretroviral medicines when their immune systems are relatively healthy as opposed to delaying therapy until the disease has advanced, they are 96 percent less likely to transmit the virus to their uninfected partners. Findings from the trial, first announced in May, were published in the New England Journal of Medicine in August. The complete top 10 list of 2011 scientific breakthroughs appears in the Dec. 23, 2011, issue of Science.

"The HPTN 052 study convincingly demonstrated that antiretroviral medications can not only treat but also prevent the transmission of HIV infection among heterosexual individuals," said NIAID Director Anthony S. Fauci, M.D. "We are pleased that Science recognized the extraordinary public health significance of these study results. This recognition also is a credit to the hard work and dedication of the HPTN 052 researchers and the more than 3,000 study participants who selflessly gave their time and energy to make such a significant contribution to the fight against HIV/AIDS."

Led by study chair Myron Cohen, M.D., director of the Institute for Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill, HPTN 052 began in 2005 and enrolled 1,763 heterosexual couples in Botswana, Brazil, India, Kenya, Malawi, South Africa, Thailand, the United States and Zimbabwe. Each couple included one partner with HIV infection. The investigators randomly assigned each couple to either one of two study groups. In the first group, the HIV-infected partner immediately began taking a combination of three antiretroviral drugs. The participants infected with HIV were extensively counseled on the need to consistently take the medications as directed. Outstanding compliance resulted in the nearly complete suppression of HIV in the blood (viral load) of the treated study participants in group one.

In the second group (the deferred group), the HIV-infected partners began antiretroviral therapy when their CD4+ T-cell levels—a key measure of immune system health—fell below 250 cells per cubic millimeter or an AIDS-related event occurred. The HIV-infected participants also were counseled on the need to strictly adhere to the treatment regimen.

The study was slated to end in 2015, but an interim data review in May by an independent data and safety monitoring board (DSMB) found that of the total 28 cases of HIV infection among the previously uninfected partners, only one case occurred among those couples where the HIV-infected partner began immediate antiretroviral therapy. The DSMB, therefore, called for immediate public release of the study's findings.

The magnitude of protection against HIV infection demonstrated in HPTN 052 has made the successful strategy of the clinical trial a key component of public health policies recently discussed by federal officials and others saying that achieving an end to the HIV/AIDS pandemic is now feasible with additional research and implementation efforts.

"On its own, treatment as prevention is not going to solve the global HIV/AIDS problem," said Dr. Fauci. "Yet when used in combination with other HIV prevention methods—such as knowing one's HIV status through routine testing, proper and consistent condom use, behavioral modification, needle and syringe exchange programs for injection drug users, voluntary, medically supervised adult male circumcision, preventing mother-to-child transmission, and, under some circumstances, antiretroviral use among HIV-negative individuals—we now have a remarkable collection of public health tools that can make a significant impact on the HIV/AIDS pandemic."

"Scale-up of these proven prevention methods combined with continued research toward a preventive HIV vaccine and female-controlled HIV prevention tools places us on a path to achieving something previously unimaginable: an AIDS-free generation," Dr. Fauci added.

### HPTN 052 was conducted by the HIV Prevention Trials Network, which is largely funded by NIAID with additional funding from the National Institute on Drug Abuse and the National Institute of Mental Health, both part of the NIH.

For additional information about the HPTN 052 study, see the Questions and Answers (http://www.niaid.nih.gov/news/QA/Pages/HPTN052qa.aspx). Visit the NIAID HIV/AIDS Web portal for more information about NIAID's HIV/AIDS research (http://www.niaid.nih.gov/topics/HIVAIDS/Pages/default.aspx).

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov. References: J. Cohen. Breakthrough of the Year: HIV Treatment as Prevention. Science Vol. 34, Dec. 23, 2011, 1628-1629.

M.S. Cohen et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. New England Journal of Medicine DOI: 10.1056/NEJMoa1105243 (2011).

ELSE PRESS RELEASES FROM THIS DATE:

Enzyme that flips switch on cells' sugar cravings could be anti-cancer target

2011-12-23

Cancer cells tend to take up more glucose than healthy cells, and researchers are increasingly interested in exploiting this tendency with drugs that target cancer cells' altered metabolism. Cancer cells' sugar cravings arise partly because they turn off their mitochondria, power sources that burn glucose efficiently, in favor of a more inefficient mode of using glucose. They benefit because the byproducts can be used as building blocks for fast-growing cells. Scientists at Winship Cancer Institute of Emory University have shown that many types of cancer cells flip ...

Project Educates Mothers to Avoid Unnecessary C-Sections

2011-12-23

Michigan hospitals are becoming the first of their kind in implementing a project that aims to avoid unnecessary C-sections. A lower rate of C-section deliveries is associated with healthier babies and a lower risk of a birth injury. The Michigan Health and Hospital Association Keystone obstetrics project implements changes to hospitals in Michigan in their birthing procedures. The project discourages elective or C-section births unless it is for medically necessary reasons such as chronic disease, a mother carrying multiple babies or the baby is small and developing ...

New technique makes it easier to etch semiconductors

2011-12-23

CHAMPAIGN, Ill. — Creating semiconductor structures for high-end optoelectronic devices just got easier, thanks to University of Illinois researchers. The team developed a method to chemically etch patterned arrays in the semiconductor gallium arsenide, used in solar cells, lasers, light emitting diodes (LEDs), field effect transistors (FETs), capacitors and sensors. Led by electrical and computer engineering professor Xiuling Li, the researchers describe their technique in the journal Nano Letters. A semiconductor's physical properties can vary depending on its structure, ...

Promising treatments for blood cancers presented by JTCancerCenter researchers at ASH meeting

2011-12-23

HACKENSACK, N.J. (December 22, 2011) — Researchers from the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 best hospitals for cancer, presented results from 31 major studies of blood-related cancers – leukemia, lymphoma and multiple myeloma -- during the American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011 in San Diego. Research highlights from the John Theurer Cancer Center included a global clinical trial of a new type of medication (HDAC inhibitor) against relapsed multiple myeloma led at the John ...

Pitt/Children's Hospital team: Cell membrane proteins could provide targets for broader vaccines

2011-12-23

PITTSBURGH, Dec. 22 – Vaccines with broader reach might be made by stimulating specialized immune cells to recognize foreign cell membrane proteins that are shared across bacterial species, say researchers from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine in a report published online today in Immunity. The approach could be particularly beneficial in preventing infection by multi-drug resistant organisms. The genetic heritage of organisms such as oysters, frogs and fish indicate that a family of cell-signaling molecules ...

MSU chemists become the first to solve an 84-year-old theory

2011-12-23

EAST LANSING, Mich. — The same principle that causes figure skaters to spin faster as they draw their arms into their bodies has now been used by Michigan State University researchers to understand how molecules move energy around following the absorption of light. Conservation of angular momentum is a fundamental property of nature, one that astronomers use to detect the presence of satellites circling distant planets. In 1927, it was proposed that this principle should apply to chemical reactions, but a clear demonstration has never been achieved. In the current issue ...

Sea cucumbers: Dissolving coral reefs?

2011-12-23

Washington, D.C. — Coral reefs are extremely diverse ecosystems that support enormous biodiversity. But they are at risk. Carbon dioxide emissions are acidifying the ocean, threatening reefs and other marine organisms. New research led by Carnegie's Kenneth Schneider analyzed the role of sea cucumbers in portions of the Great Barrier Reef and determined that their dietary process of dissolving calcium carbonate (CaCO3) from the surrounding reef accounts for about half of at the total nighttime dissolution for the reef. The work is published December 23 by the Journal of ...

$144 Million Dollar Verdict Awarded in Birth Trauma Case

2011-12-23

Nearly five years after an initial lawsuit was filed, a jury in Michigan recently handed down a $144 million dollar verdict against Beaumont Hospital for injuries sustained during childbirth. Kimberly VanSlembrouck initiated the lawsuit against the hospital claiming they were negligent in their actions while she gave birth, causing her daughter irrevocable birth injuries. According to VanSlembrouck, the hospital was negligent when it failed to perform a Caesarian section, but instead delivered her daughter through the birth canal. As a result, her daughter suffered a ...

New device could bring optical information processing

2011-12-23

WEST LAFAYETTE, Ind. - Researchers have created a new type of optical device small enough to fit millions on a computer chip that could lead to faster, more powerful information processing and supercomputers. The "passive optical diode" is made from two tiny silicon rings measuring 10 microns in diameter, or about one-tenth the width of a human hair. Unlike other optical diodes, it does not require external assistance to transmit signals and can be readily integrated into computer chips. The diode is capable of "nonreciprocal transmission," meaning it transmits ...

DOE researchers achieve important genetic breakthroughs to help develop cheaper biofuels

2011-12-23

Washington D.C. – Researchers at the U.S. Department of Energy's (DOE's) Joint BioEnergy Institute (JBEI) announced today a major breakthrough in engineering systems of RNA molecules through computer-assisted design, which could lead to important improvements across a range of industries, including the development of cheaper advanced biofuels. Scientists will use these new "RNA machines", to adjust genetic expression in the cells of microorganisms. This will enable scientists to develop new strains of Escherichia coli (E. coli) that are better able to digest switchgrass ...

HIV study named 2011 breakthrough of the year by Science

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: